| Financial Year |
March 31 2023 |
| Monetary Funds |
61,764,911.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
45,532,806.86 |
| Advances to Suppliers |
11,901,785.31 |
| Other Receivables |
72,425,748.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
740,144,014.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
794,159.65 |
| Total Current Assets |
932,563,426.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
425,004,297.31 |
| Investment Properties |
56,743,787.22 |
| Fixed Assetes |
2,438,471,163.63 |
| Under-construction Projects |
428,013,343.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
411,808,081.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
81,117,049.57 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
25,866,042.07 |
| Sub-Total of Non-Current Assets |
4,163,209,335.86 |
| Total Assets |
5,095,772,762.53 |
| Short-Term Loans |
1,574,565,730.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,568,962.56 |
| Accounts Payable |
225,507,359.06 |
| Accounts Received In Advance |
2,771,057.55 |
| Employee Compensation Payable |
10,780,503.11 |
| Taxes Payable |
15,144,408.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,149,756,247.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
147,569,661.10 |
| Other Current Liabilities |
3,346,811.34 |
| Sub-Total of Current Liabilities |
3,192,828,489.41 |
| Long-term Loans |
290,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
22,806,726.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,378,370.92 |
| Deferred Income Tax Liabilities |
88,848,244.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
578,638,488.36 |
| Total Liabilities |
3,771,466,977.77 |
| Paid-In Capital(Or Share Stock) |
1,018,926,000.00 |
| Capital Surplus |
1,452,046,237.70 |
| Surplus Reserve |
84,959,968.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-818,008,962.05 |
| Minority Stockholder's Interest |
-438,837,516.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,763,143,301.12 |
| Owner's Equity（Stockholder's Equity） |
1,324,305,784.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,095,772,762.53 |
